Oxidative–Antioxidative Markers in Pregnant Women with Fetal Neural Tube Defects

Abstract Objective We compared markers of oxidative stress (OS) in mothers with and without fetal neural tube defects (NTDs). Methods: Pregnant mothers in the second trimester with NTD-affected fetuses and age, gestational age, and body mass index-matched control mothers with unaffected fetuses were included. Maternal serum thiol-disulfide homeostasis parameters and ischemia-modified albumin (IMA) were measured. Results: In 30 affected mothers compared to 31 controls, disulfide levels, disulfide/native thiol, and disulfide/total thiol ratios were higher; native and total thiol levels and native thiol/total thiol ratios were lower (p < 0.001). Mothers with NTD-affected fetuses had higher levels of IMA than controls (p = 0.025). Conclusion: The thiol-disulfide homeostasis balance was shifted in favor of disulfide, suggesting increased thiol oxidation and OS in the second trimester of NTD-affected pregnancies. Maternal levels of IMA, an oxidatively altered form of albumin, thus a measure of OS, were higher in NTD-affected second trimester pregnancies compared to controls.

[1]  O. Erel,et al.  Dynamic Thiol/Disulfide Homeostasis in Predicting Adverse Neonatal Outcomes in Fetal Growth Restriction , 2020, Fetal and pediatric pathology.

[2]  O. Erel,et al.  Thiol/Disulfide Homeostasis in Patients with Molar Pregnancies , 2020, Fetal and pediatric pathology.

[3]  R. Finnell,et al.  Network correlation analysis revealed potential new mechanisms for neural tube defects beyond folic acid. , 2018, Birth defects research.

[4]  Y. Aratani.  Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. , 2018, Archives of biochemistry and biophysics.

[5]  O. Erel,et al.  The significance of thiol/disulfide homeostasis and ischemia-modified albumin levels to assess the oxidative stress in patients with different stages of diabetes mellitus , 2018, Scandinavian journal of clinical and laboratory investigation.

[6]  Ö. Erel,et al.  Maternal serum thiol/disulfide homeostasis in pregnancies complicated by neural tube defects: report of a preliminary study , 2017, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[7]  Aslı Yarcı Gursoy,et al.  Ischemia modified albumin in perinatology. , 2017, European journal of obstetrics, gynecology, and reproductive biology.

[8]  O. Erel,et al.  Impact of Gestational Diabetes Mellitus and Maternal Obesity on Cord Blood Dynamic Thiol/Disulfide Homeostasis , 2017, Fetal and pediatric pathology.

[9]  O. Erel,et al.  Relationship between maternal blood ceruloplasmin level, catalase and myeloperoxidase activity and neural tube defects. , 2017, Ginekologia polska.

[10]  E. Dimova,et al.  Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved? , 2015, Redox biology.

[11]  E. A. Reece,et al.  Decoding the oxidative stress hypothesis in diabetic embryopathy through proapoptotic kinase signaling. , 2015, American journal of obstetrics and gynecology.

[12]  E. A. Reece,et al.  Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis. , 2015, World journal of diabetes.

[13]  Jufen Liu,et al.  Markers of macromolecular oxidative damage in maternal serum and risk of neural tube defects in offspring. , 2015, Free radical biology & medicine.

[14]  O. Erel,et al.  A novel and automated assay for thiol/disulphide homeostasis. , 2014, Clinical biochemistry.

[15]  A. Pereira,et al.  Oxidative stress in pregnancy and fertility pathologies , 2014, Cell Biology and Toxicology.

[16]  N. Greene,et al.  Neural tube defects: recent advances, unsolved questions, and controversies , 2013, The Lancet Neurology.

[17]  Omer Kalayci,et al.  Oxidative Stress and Antioxidant Defense , 2012, The World Allergy Organization journal.

[18]  H. Yaman,et al.  Serum ischemia modified albumin levels in pregnancies with neural tube defects. , 2012, The Journal of reproductive medicine.

[19]  M. Melek,et al.  Relationship of antioxidant enzyme activities with myelomeningocele. , 2012, Turkish neurosurgery.

[20]  L. Winn,et al.  Valproic Acid Increases Formation of Reactive Oxygen Species and Induces Apoptosis in Postimplantation Embryos: A Role for Oxidative Stress in Valproic Acid-Induced Neural Tube Defects , 2011, Molecular Pharmacology.

[21]  H. Toy,et al.  Amniotic Fluid Prolidase Activity and Oxidative Status in Neural Tube Defects , 2010, Fetal Diagnosis and Therapy.

[22]  A. Noguera,et al.  Oxidative stress in mothers who have conceived fetus with neural tube defects: the role of aminothiols and selenium. , 2004, Clinical nutrition.

[23]  D. Bar-Or,et al.  A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. , 2000, The Journal of emergency medicine.

[24]  M. Gnant,et al.  Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.

[25]  L. Góth,et al.  A simple method for determination of serum catalase activity and revision of reference range. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[26]  D. Priebat,et al.  Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. , 1982, The Journal of investigative dermatology.